2024 Confirmed Partners
Lead Partner:
Cytiva
Lead Partner
Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients.
We are part of Danaher, a global science and technology leader. Along with other Danaher businesses, we accelerate the impact of tomorrow’s science and technology innovation to improve human health.
Program Partners:
Areterna: A Synthgene Company
Program Partner
Areterna LLC was founded in 2023 as a wholly-owned subsidiary of Synthgene Biotechnology Co., Ltd. to serve customers in the US and Europe.
Synthgene is a company that provides materials and services to support mRNA and oligonucleotide manufacturing. Founded in 2018 by a group of passionate nucleic acid chemists, the goal of the company is to debottleneck the raw material supply and develop innovative solutions to support customers in the industry. The company has a robust quality system and ISO9001 certification to support cGMP manufacturing of mRNA raw materials that include NTPs, modified NTPs and cap analogs. For the GMP raw materials, Drug Master Files have been filed with FDA. In addition, Synthgene offers analytical development service and mRNA-related impurity standards and detection kits, LNP screening service, IVT process development and IVT kits for mRNA research. For solid-phase DNA and RNA synthesis, Synthgene offers high quality phosphonamidites to support cGMP oligo manufacturing. With over 200 scientists in R&D and AI-assisted discovery platform, Synthgene will continue to bring new products to the market.
Beckman Coulter
Program Partner
Beckman Coulter Inc. is one of the world’s leading manufacturers of measuring instruments and test assays in the field of life science and clinical diagnostics. For the discovery and development of new drugs, their production and medical diagnostics, scientists today need state-of-the-art tools and services to investigate complex biological systems and questions. Beckman Coulter Life Science supports our customers from the scientific, biotech and pharmaceutical sectors with a wide range of systems for the analysis of cells, proteins, particles and genomic materials. Whether pipetting robots or centrifuges, devices for cellular analysis or flow cytometry, antibodies for immunological assays or kits for genomic questions - all these solutions help today’s scientists to answer the challenging questions in the best possible way.
Corden Pharma
Program Partner
CordenPharma offers advanced LNP formulation technologies, back-integrated lipid synthesis, and forward-integrated sterile injectable manufacturing services to create a proven, truly integrated, commercialization pathway for your xRNA based therapeutics. Our LNP manufacturing strategies, based on ethanol injection, are tailored to encapsulate a broad variety of genetic payloads. We also offer LNP Starter Kits (which provide researchers the essential components needed to create and optimize their own LNPs for xRNA/xDNA delivery), key standard and proprietary lipids ideally suited for mRNA applications, and support sterile injectable PFS, vials, ampoules & lyophilized vials with a wide range of filling volumes.
Etherna
Program Partner
We are an RNA technology company, with over 30 years’ experience, offering professional partnership to pharma and biotech with an emerging or established interest in RNA therapeutics. Our expert team supports start-up, early stage and late stage projects by using our proprietary platforms across RNA chemistry, LNP formulation and Process Technology, to drive new pipeline development or resolve manufacturing challenges for our partners.
NOF
Program Partner
NOF CORPORATION is the leading commercial supplier of GMP grade activated PEGs, lipids and ultrapure Polysorbates 80 for drug delivery products through R&D to commercial scale. We provide a wide range of lipids (ionizable, PEG, and phospho) for lipid nanoparticle formulations (LNP). Our LNP platform, containing our ionizable lipid (COATSOME® SS Series), has excellent endosomal escape ability and provides high gene expression with low toxicity. It is capable of applying to gene delivery, gene editing, and RNA vaccine application under this platform.
ReciBioPharm
Program Partner
ReciBioPharm is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize advanced therapy medicinal products (ATMPs).
ReciBioPharm’s specialized CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production.
Headed by a management team and technical experts with a proven track record in both process development and contract manufacturing, ReciBioPharm offers the knowledge and resources necessary to help customers develop and manufacture promising new therapies to meet the needs of patients across the world.
WuXi TIDES
Program Partner
WuXi TIDES, a unique Contract Research and Development Manufacturing Organization (CRDMO) platform, is an integral part of WuXi STA, a subsidiary of WuXi AppTec. WuXi TIDES offers our worldwide partners efficient, flexible, and high-quality solutions for the drug development of oligonucleotides, peptides and related synthetic conjugates (“TIDES” drugs). We greatly simplify the TIDES drug development by providing all discovery, CMC development and the entire manufacturing supply chain under one roof.
Innovation Partners:
Curapath
Innovation Partner
Curapath provides unmatched technical and analytical expertise in the custom design, development, and end-to-end GMP manufacture of polymer and lipid-based drug delivery systems to support cell therapy, gene therapy, and vaccine delivery. Our expertise in functional polymer and lipid excipients, formulation, and manufacturing of nanoparticles make Curapath the right partner to drive your therapeutic development. We deliver consultative, hands-on guidance from preclinical development through commercial-scale GMP manufacturing. Curapath is a knowledgeable partner you can trust to move fast, manufacture smart, and provide support through your drug development journey, accelerating your speed to the clinic. We help our partners solve even the most complex drug delivery challenges.
FUJIFILM
Innovation Partner
FUJIFILM Corporation is transforming into a healthcare company through leveraging fine-chemical technologies cultivated in photo-films’ manufacturing, such as organic-chemistry and nanotechnologies. Based on these assets, we have started one-stop CDMO service from bench top formulation research to GMP manufacturing for lipid nanoparticles utilizing Fujifilm's proprietary ionizable lipids.
Helix Biotech
Innovation Partner
Helix Biotech is a Customer and Quality focused CDMO specializing in LNPs, Liposomes, and Hybrid Nanoparticles. Browse our selection of innovative tools and reagent systems, or reach out to us for assistance with your pre-clinical or clinical stage development, manufacturing, and analytical project.
InProcess-LSP
Innovation Partner
InProcess-LSP is a highly innovative organization providing full Process Analytical Technology (PAT) method and instrument development services. It was founded in 2014 and is based at Pivot Park High Tech Pharma campus in The Netherlands.
Being experts in nanoparticle size characterization, they are the inventors of the NanoFlowSizer: a unique, non-invasive nanoparticle size instrumentation for real-time measurement. Nanoparticle sizing takes place within seconds, enabling continuous real-time in flow analysis.
The NanoFlowSizer is the only instrument capable of measuring particle size and size distribution of turbid nanosuspensions in flow, without the need for sample treatment.
KNAUER
Innovation Partner
KNAUER are a berlin-based manufacturer of high-tech scientific instruments, whose strength lies in liquid engineering.
KNAUER manufactures systems for the production of lipid nanoparticle-based formulations, such as mRNA vaccines. Their NanoProducer units, which use KNAUER’s Impingement Jets Mixing (IJM) technology, are used worldwide in the high-volume production of mRNA COVID-19 vaccines.
Their latest LNP system, the NanoScaler, is designed specifically for the pre-scale up R&D of new mRNA therapies.
Think LNP. Think KNAUER.
Lipoid
Innovation Partner
Since its foundation in 1977, Lipoid has gained an outstanding reputation in the development and industrial production of high-quality lecithin, phospholipids, and other lipid products, meeting the high standards of the pharmaceutical industry. Lipoid is the world’s leading company for the production and supply of a wide range of natural and synthetic phospholipid excipients on an industrial scale.
NanoFCM
Innovation Partner
NanoFCM designs advanced analytical instrumentation allowing the measurement of biological and synthetic substrates, such as lipid nanoparticles, extracellular vesicles and viruses. The NanoAnalyzer platform offers a flexible, high throughput solution to for the single-particle, multiparameter characterisation of novel nano-sized therapeutics using nano-flow cytometry. By measuring simultaneously physical size, concentration and therapeutic content, the NanoAnalyzer can assess the encapsulation rate of API in individual nanoparticles, speeding-up development, approval and quality control of novel drugs and vaccines.
Unchained Labs
Innovation Partner
Here’s the deal. We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
Exhibition Partners:
Ardena
Exhibition Partner
Ardena is your premier integrated CDMO and leading nanomedicine partner, with a special focus on LNP (Lipid Nanoparticle) development. Our unparalleled service portfolio encompasses the entire LNP lifecycle, from early development to GMP manufacturing of payloads and LNPs. Additionally, we offer GMP aseptic fill-finish, clinical packaging, bioanalysis, and CMC regulatory support. Experience the seamless journey from concept to clinic with Ardena's comprehensive and expertly integrated LNP services.
Avanti Polar Lipids
Exhibition Partner
Whatever your requirement, Croda Pharma’s extensive portfolio of Avanti lipids can meet your needs. We offer both research grade and GMP grade lipids to support discovery, clinical, and commercial LNP manufacturing requirements including an extensive portfolio of phospholipids, PEG lipids, cationic lipids, functionalized lipids, sterols, and more. In addition, we specialize in custom lipid manufacturing of proprietary compounds, lipid formulation development, and preparation of custom lipid blends to make your project a success.
Cayman Chemical
Exhibition Partner
Partner with Cayman and utilize 42 years’ experience in synthesis, purification, and characterization of lipids. Cayman manufactures an expansive selection of high-purity lipids utilized in LNP and liposome development including commercial and custom phospholipids, cationic and, anionic lipids. Our client-focused services include custom synthesis, purification, characterization, and custom API manufacturing. We couple your vision with our expertise to match your payload with the world’s best lipids and lipid chemists.
JenKem Technology
Exhibition Partner
JenKem Technology manufactures small molecules, lipids, and related PEG-lipid intermediates for LNPs used for mRNA delivery, as well as for Cell Penetrating Peptide PEG products for siRNA delivery.
JenKem Technology supplies PEG derivatives worldwide, from R&D through preclinical, clinical trials, and GMP commercial quantities for pharmaceuticals, biotech, medical devices, and diagnostics. DMFs were filed with China CDE and US FDA for several of these products. PEGylation services are available up to pre-clinical stage.
Levitronix
Exhibition Partner
Levitronix® is the worldwide leader in magnetically levitated bearingless motor technology, specializing in supplying process equipment for Biotech, Microelectronics and Industrial Applications. Levitronix’ products range from pump systems, mixers, flow control systems and blowers to flow sensors and viscometers.
Novel, targeted ways to treat diseases like gene therapy, DNA and mRNA vaccines, exosomes, and stem cells imply new manufacturing challenges. Dealing with very shear sensitive particles like cells, LNPs or viral vectors, especially in a continuous, sterile, or single-use processes, relate to new process equipment requirements. Levitronix® process equipment is intended to handle demanding fluid applications ensuring the highest product yields. Levitronix® PuraLev® pumps are ultra-low shear and pulsation-free by design, minimizing particle degradation or aggregation. Levitronix® LEVIFLOW® flow sensors ensure high-precision flow measurement.
Levitronix pulsation free, high-precision flow control systems make it the perfect fit for (m)RNA / lipid mixing systems for LNP formulation applications.
Malvern Panalytical
Exhibition Partner
When you can make the invisible visible, you make the impossible possible. Malvern Panalytical is the leading supplier of innovative chemical, biophysical and structural characterization solutions along with drug discovery, development, and research services. Our knowledge and expertise address the analytical challenges in this field, delivering tangible economic impact.
Micro&Nano
Exhibition Partner
Micro&Nano Biologics Co.,LTD. was formally established in early 2020 when founded in 2018. Micro & Nano is a company focusing on providing integrated solutions for the development of nano delivery of genomic medicines and has acquired more than 20 invention patents (PCT included) in related field.
Micro & Nano has built the first integrated nucleic acid delivery process equipment R&D and production center in Shanghai, which can provide process and customization support to customers. The company is now focusing on RNA drug delivery equipment (laboratory to cGMP production) and process development, production, manufacturing, and has served more than 200 head pharmaceutical companies and research institutes at home and abroad, which has helped many customers to obtain IND clinical approvals for nucleic acid drugs in China, the United States, Brazil, Australia, etc.
NanoImaging Services
Exhibition Partner
Having a clear picture of nanomedicine formulations, like vaccine, gene, and drug delivery vehicles can mitigate the risk for unexpected complications. CryoEM simultaneously assesses drug encapsulation, morphology, lamellarity, impurities, integrity, and aggregation, and is a powerful, orthogonal technique in any analytical toolkit. NIS provides rapid, flexible and cost-effective access to cryoEM with expert knowledge and established infrastructure to accelerate projects and gain a better understanding of your formulations.
ONI
Exhibition Partner
Founded in 2016, ONI is now a leading and rapidly growing life science company redefining the boundaries of scientific discovery with super-resolution microscopy. The Nanoimager, ONI’s flagship product, is the world’s first desktop super-resolution microscope, capable of visualizing, tracking and imaging individual molecules in living cells with 20 nm resolution. Each team at ONI – from scientists to software engineers to sales teams – wants to create and provide innovative technologies that will empower researchers and users alike. We want to accelerate human discovery and fight disease and in doing so drive super-resolution microscopy to novel frontiers.
Pace
Exhibition Partner
For decades, Pace® has been committed to advancing science to ensure the health and safety of our communities and lives. We partner with you to provide the service, science, and data you need to make critical decisions that benefit us all. Join us in working together to protect our environment and improve our health.
Phosphorex
Exhibition Partner
Phosphorex is a leading provider of drug delivery technologies and solutions. By harnessing the potential of microspheres and nanoparticles for drug delivery, Phosphorex offers tailored solutions and enabling technologies to optimize a drug's release rate, targeting ability, bioavailability, and deliverability, with the goal of achieving desired therapeutic effects while reducing adverse clinical outcomes. Phosphorex supports pharmaceutical and biotech companies through all phases of their development, from proof of concept to clinical studies. Phosphorex's mission is to help our partners solve complex problems and develop successful drugs to help patients.
Polypus Transfection
Exhibition Partner
Polyplus, part of Sartorius, is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale.
An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services for viral and non-viral delivery. Custom plasmid vector design and plasmid and protein manufacturing was integrated into the offer in 2022 to expand the products and services portfolio to help the industry optimize process economics while meeting strict scientific and regulatory standards.
Polyscience
Exhibition Partner
Kyfora Bio, Polysciences bioprocessing brand, supports development of cell and gene therapy (CGT) breakthroughs from bench to clinic. Backed by 60+ years of specialty chemical development, manufacturing, and application expertise, Kyfora provides research grade through cGMP transfection reagents and excipients for viral vectors, mRNA vaccines, and other drug delivery applications. Our cost-effective and scalable cGMP processes empower advanced therapies to improve patients’ lives.
Resilience
Exhibition Partner
Resilience is a first-of-kind technology company dedicated to broadening access to complex medicines and to protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end biomanufacturing solutions to help ensure the medicines of today and tomorrow can be made quickly, safely and at scale to meet patient needs. We provide solutions across five key modalities: Nucleic Acids, Cell Therapy, Gene Therapy, Vaccines & Biologics. Our non-viral nucleic acid therapeutics business model aims to help you save time and manufacturing cost by providing access to world-class expertise and modular biomanufacturing capabilities at all scales.
Sinopeg
Exhibition Partner
Xiamen Sinopeg Biotech Co., Ltd. is dedicated to drug delivery systems and related medical device business, focusing on the research, development, production and sales of high-end drug delivery carriers/auxiliary materials/APIs, medical materials, including but not limited to polyethylene glycol derivatives, lipid products, blood sugar control drug modifiers, block copolymers, ADC/ProTAC linkers, biodegradable polymers, exosomes, viral-like particles, as well as providing CDMO and solution services. These products are widely used in long-acting protein/peptide drugs, COVID-19 mRNA vaccines, small nucleic acid drugs, blood sugar control drugs, macromolecular micelle drugs, liposome drugs, gene therapy drugs, immunosuppressants, ADC drugs, ProTAC drugs, medical hydrogels, and other fields, placing the company in a leading position in the industry.
SINOPEG holds 31 IP, 25 pending IP, and 16 DMFs that meet FDA requirements. The company has ISO13485 certification. The laboratory and production workshop are designed and built in accordance with the cGMP standard of FDA. We follow the requirements of ICH-Q7A to organize production at scale, to provide high quality polyethylene glycol derivatives products and services to customers globally.
Spectradyne
Exhibition Partner
Spectradyne’s ARC™️ nanoparticle analysis system combines two orthogonal methods in a single system, for LNP size, concentration, payload analysis and surface targeting information. The ARC system overcomes all the limitations found with other technologies such as fluorescence NTA and flow cytometry.
- Simultaneous particle size, concentration & fluorescence-based phenotyping/payload measurement
- Electrical & optical: Simultaneous orthogonal measurements
- Quantitative, traceable fluorescence units (ERF or MESF)
- Compatible with traditional dyes & staining protocols (no wash steps required)
- Microliter sample sizes
- Works in complex backgrounds (serum, plasma)
Wacker
Exhibition Partner
Wacker Wacker is a full-service contract manufacturer of messenger ribonucleic acid (mRNA), plasmid DNA (pDNA), therapeutic proteins, live microbial products, and vaccines based on microbial systems. Wacker Biotech’s mRNA portfolio includes production of pDNA as starting material for mRNA, production of mRNA as well as LNP formulation in one hand (one-stop-shop) with a fully equipped, stocked and dedicated facility to produce GMP-grade mRNA to meet the highest quality standards and regulatory compliance. The production plants in Jena, Halle and Amsterdam are FDA- and EMA-certified.
Event Partners:
Information Partner:
US Pharmacopeia
Information Partner
USP is an independent scientific organization that collaborates with the world's top experts in health and science to develop quality resources and standards for medicines, active ingredients and excipients, dietary supplements and food ingredients. Through our resources, standards, advocacy and education, USP helps ensure the availability of quality medicines, excipients, supplements and foods for billions of people worldwide.
What Your Peers Have To Say:
"With increased scientific interest in delivery technologies, it’s important to stay up to date on the emerging LNP field and learn together as a delivery sciences community."
Julie Shi, Associate Director, Non-Viral Delivery, Cell Therapy Development, BMS
"Maintaining understanding of state of the art LNP technology as it may apply to accessible products in low and middle income countries"
Dennis Lee, Senior Program Officer, Bill & Mellinda Gates Foundation